ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 170 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,652 | -27.9% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $5,066 | +7.1% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $4,730 | +23.4% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $3,832 | -10.9% | 150 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $4,302 | +19.6% | 150 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $3,596 | +41.4% | 150 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $2,544 | +27.2% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
| Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
| Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
| ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
| SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
| Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
| Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
| FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
| Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
| Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |